tiprankstipranks
Krishna Institute of Medical Sciences Limited (IN:KIMS)
:KIMS
India Market
Want to see IN:KIMS full AI Analyst Report?

Krishna Institute of Medical Sciences Limited (KIMS) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

KIMS Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Krishna
Institute of Medical Sciences Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

KIMS Stock 12 Month Forecast

There Are No Analyst Ratings for IN:KIMS In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

KIMS Financial Forecast

KIMS Earnings Forecast

Next quarter’s earnings estimate for KIMS is ₹1.97 with a range of ₹1.14 to ₹2.80. The previous quarter’s EPS was ₹1.20. KIMS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year KIMS has Performed in-line its overall industry.
Next quarter’s earnings estimate for KIMS is ₹1.97 with a range of ₹1.14 to ₹2.80. The previous quarter’s EPS was ₹1.20. KIMS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year KIMS has Performed in-line its overall industry.

KIMS Sales Forecast

Next quarter’s sales forecast for KIMS is ₹12.11B with a range of ₹11.58B to ₹12.63B. The previous quarter’s sales results were ₹10.75B. KIMS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year KIMS has Performed in-line its overall industry.
Next quarter’s sales forecast for KIMS is ₹12.11B with a range of ₹11.58B to ₹12.63B. The previous quarter’s sales results were ₹10.75B. KIMS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year KIMS has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Geojit Research Analyst forecast on IN:KIMS
Geojit Research
Geojit Research
₹812₹780
Buy
19.45%
Upside
Reiterated
02/19/26
Geojit Research Sticks to Its Buy Rating for Krishna Institute of Medical Sciences Limited (KIMS)
Axis Direct Analyst forecast on IN:KIMS
Unknown Analyst
Axis Direct
Not Ranked
Axis Direct
₹760
Buy
16.39%
Upside
Reiterated
02/10/26
Axis Direct Reaffirms Their Buy Rating on Krishna Institute of Medical Sciences Limited (KIMS)
ICICI Securities Analyst forecast on IN:KIMS
Unknown Analyst
ICICI Securities
Not Ranked
ICICI Securities
₹820
Buy
25.57%
Upside
Reiterated
02/10/26
Krishna Institute of Medical Sciences Limited (KIMS) Receives a Buy from ICICI Securities
Prabhudas Lilladher Analyst forecast on IN:KIMS
Unknown Analyst
Prabhudas Lilladher
Not Ranked
Prabhudas Lilladher
₹810
Buy
24.04%
Upside
Reiterated
02/09/26
Krishna Institute of Medical Sciences Limited (KIMS) Gets a Buy from Prabhudas Lilladher
Goldman Sachs Analyst forecast on IN:KIMS
Goldman Sachs
Goldman Sachs
₹900
Buy
37.83%
Upside
Initiated
12/07/25
HSBC
₹805₹810
Buy
24.04%
Upside
Reiterated
10/09/25
Krishna Institute of Medical Sciences Limited (KIMS) Gets a Buy from HSBC
Kotak Mahindra Analyst forecast on IN:KIMS
Kotak Mahindra
Kotak Mahindra
₹685₹730
Sell
11.79%
Upside
Downgraded
08/08/25
Kotak Mahindra downgrades Krishna Institute of Medical Sciences Limited (KIMS) to a Sell
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Geojit Research Analyst forecast on IN:KIMS
Geojit Research
Geojit Research
₹812₹780
Buy
19.45%
Upside
Reiterated
02/19/26
Geojit Research Sticks to Its Buy Rating for Krishna Institute of Medical Sciences Limited (KIMS)
Axis Direct Analyst forecast on IN:KIMS
Unknown Analyst
Axis Direct
Not Ranked
Axis Direct
₹760
Buy
16.39%
Upside
Reiterated
02/10/26
Axis Direct Reaffirms Their Buy Rating on Krishna Institute of Medical Sciences Limited (KIMS)
ICICI Securities Analyst forecast on IN:KIMS
Unknown Analyst
ICICI Securities
Not Ranked
ICICI Securities
₹820
Buy
25.57%
Upside
Reiterated
02/10/26
Krishna Institute of Medical Sciences Limited (KIMS) Receives a Buy from ICICI Securities
Prabhudas Lilladher Analyst forecast on IN:KIMS
Unknown Analyst
Prabhudas Lilladher
Not Ranked
Prabhudas Lilladher
₹810
Buy
24.04%
Upside
Reiterated
02/09/26
Krishna Institute of Medical Sciences Limited (KIMS) Gets a Buy from Prabhudas Lilladher
Goldman Sachs Analyst forecast on IN:KIMS
Goldman Sachs
Goldman Sachs
₹900
Buy
37.83%
Upside
Initiated
12/07/25
HSBC
₹805₹810
Buy
24.04%
Upside
Reiterated
10/09/25
Krishna Institute of Medical Sciences Limited (KIMS) Gets a Buy from HSBC
Kotak Mahindra Analyst forecast on IN:KIMS
Kotak Mahindra
Kotak Mahindra
₹685₹730
Sell
11.79%
Upside
Downgraded
08/08/25
Kotak Mahindra downgrades Krishna Institute of Medical Sciences Limited (KIMS) to a Sell
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Krishna Institute of Medical Sciences Limited

3 Months
Alankar GarudeKotak Mahindra
Success Rate
1/2 ratings generated profit
50%
Average Return
+0.85%
Copying Alankar Garude's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.85% per trade.
1 Year
Success Rate
2/3 ratings generated profit
67%
Average Return
+2.43%
Copying Damayanti Kerai's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +2.43% per trade.
2 Years
Success Rate
3/3 ratings generated profit
100%
Average Return
+9.60%
Copying Damayanti Kerai's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +9.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KIMS Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
1
5
4
4
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
5
4
4
0
In the current month, KIMS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KIMS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

KIMS Stock Forecast FAQ

What is IN:KIMS’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:KIMS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:KIMS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Krishna Institute of Medical Sciences Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Krishna Institute of Medical Sciences Limited’s share price target?
      Currently, no data Available
      What do analysts say about Krishna Institute of Medical Sciences Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Krishna Institute of Medical Sciences Limited?
      To buy shares of IN:KIMS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.